These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 17482393)
21. Implantable technology for long-term delivery of nalmefene for treatment of alcoholism. Costantini LC; Kleppner SR; McDonough J; Azar MR; Patel R Int J Pharm; 2004 Sep; 283(1-2):35-44. PubMed ID: 15363499 [TBL] [Abstract][Full Text] [Related]
22. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles. Packhaeuser CB; Kissel T J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938 [TBL] [Abstract][Full Text] [Related]
23. Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skin. Milewski M; Pinninti RR; Stinchcomb AL J Pharm Sci; 2012 Aug; 101(8):2777-86. PubMed ID: 22628183 [TBL] [Abstract][Full Text] [Related]
24. Capacity and tolerance of a new device for ocular drug delivery. Pijls RT; Cruysberg LP; Nuijts RM; Dias AA; Koole LH Int J Pharm; 2007 Aug; 341(1-2):152-61. PubMed ID: 17524579 [TBL] [Abstract][Full Text] [Related]
25. Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols. Salama RO; Traini D; Chan HK; Young PM Eur J Pharm Biopharm; 2008 Sep; 70(1):145-52. PubMed ID: 18534832 [TBL] [Abstract][Full Text] [Related]
26. A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs. Huang WC; Hu SH; Liu KH; Chen SY; Liu DM J Control Release; 2009 Nov; 139(3):221-8. PubMed ID: 19607866 [TBL] [Abstract][Full Text] [Related]
27. A novel mathematical model quantifying drug release from lipid implants. Siepmann F; Herrmann S; Winter G; Siepmann J J Control Release; 2008 Jun; 128(3):233-40. PubMed ID: 18442866 [TBL] [Abstract][Full Text] [Related]
28. Controlled release of growth hormone from thermosensitive triblock copolymer systems: In vitro and in vivo evaluation. Chen S; Singh J Int J Pharm; 2008 Mar; 352(1-2):58-65. PubMed ID: 18036752 [TBL] [Abstract][Full Text] [Related]
29. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide. Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869 [TBL] [Abstract][Full Text] [Related]
30. Multivesicular liposomes for sustained release of naltrexone hydrochloride: design, characterization and in vitro/in vivo evaluation. Sun L; Wang T; Gao L; Quan D; Feng D Pharm Dev Technol; 2013; 18(4):828-33. PubMed ID: 22759074 [TBL] [Abstract][Full Text] [Related]
31. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. Dahan A; Hoffman A J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294 [TBL] [Abstract][Full Text] [Related]
32. Histological changes over time around the site of sustained release naltrexone-poly(DL-lactide) implants in humans. Hulse GK; Stalenberg V; McCallum D; Smit W; O'neil G; Morris N; Tait RJ J Control Release; 2005 Nov; 108(1):43-55. PubMed ID: 16154223 [TBL] [Abstract][Full Text] [Related]
33. The release behavior of doxorubicin hydrochloride from medicated fibers prepared by emulsion-electrospinning. Xu X; Chen X; Ma P; Wang X; Jing X Eur J Pharm Biopharm; 2008 Sep; 70(1):165-70. PubMed ID: 18472256 [TBL] [Abstract][Full Text] [Related]
34. In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media. Sunesen VH; Pedersen BL; Kristensen HG; Müllertz A Eur J Pharm Sci; 2005 Mar; 24(4):305-13. PubMed ID: 15734297 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of long-acting naltrexone in subjects with mild to moderate hepatic impairment. Turncliff RZ; Dunbar JL; Dong Q; Silverman BL; Ehrich EW; Dilzer SC; Lasseter KC J Clin Pharmacol; 2005 Nov; 45(11):1259-67. PubMed ID: 16239359 [TBL] [Abstract][Full Text] [Related]
36. Use of synthetic polypeptides in the preparation of biodegradable delivery vehicles for narcotic antagonists. Sidman KR; Arnold DL; Steber WD; Nelsen L; Granchelli FE; Strong P; Sheth SG Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):33-8. PubMed ID: 967233 [TBL] [Abstract][Full Text] [Related]
37. An investigation into effects of in vitro test condition on the release properties of theophylline from HPMC matrices using factorial design. Petrovic A; Ibric S; Trajkovic S; Popovic R; Djuric Z; Popadic D Arch Pharm Res; 2009 Jul; 32(7):1087-96. PubMed ID: 19641891 [TBL] [Abstract][Full Text] [Related]
38. Psyllium and copolymers of 2-hydroxylethylmethacrylate and acrylamide-based novel devices for the use in colon specific antibiotic drug delivery. Singh B; Chauhan N; Kumar S; Bala R Int J Pharm; 2008 Mar; 352(1-2):74-80. PubMed ID: 18055144 [TBL] [Abstract][Full Text] [Related]
39. Simultaneous measurement of liquid-phase and solid-phase transformation kinetics in rotating disc and channel flow cell dissolution devices. Lehto P; Aaltonen J; Niemelä P; Rantanen J; Hirvonen J; Tanninen VP; Peltonen L Int J Pharm; 2008 Nov; 363(1-2):66-72. PubMed ID: 18675891 [TBL] [Abstract][Full Text] [Related]
40. A biodegradable levonorgestrel-releasing implant made of PCL/F68 compound as tested in rats and dogs. Ma G; Song C; Sun H; Yang J; Leng X Contraception; 2006 Aug; 74(2):141-7. PubMed ID: 16860052 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]